Please login to the form below

Not currently logged in
Email:
Password:

Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Adil-Zainulbhai-Cipla

India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director.

A native of India Zainulbhai moved to the US in 1979 to join consulting firm McKinsey & Company. He returned to Mumbai in 2004 to help grow the company's presence in India, working with CEOs of many of the country's largest firms across several industries.

Cipla chairman Y K Hamied said: "Adil's 30 plus years of experience across various industries in India and globally will add a valuable perspective to our board of directors."

Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to the world while building a strong company. I look forward to helping Cipla become even more successful."

29th July 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics